Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA)

Molecular Psychiatry

Volumn 7, Issue 6, 2002, Pages 626-632

  Manor, I ^a   Tyano, S ^a   Mel, E ^b   Eisenberg, J ^b   Bachner Melman, R ^b   Kotler, M ^b   Ebstein, R P ^b  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b HERZOG HOSPITAL   (Israel)

Author keywords

Association; Attention deficit hyperactivity disorder (ADHD); Complex genetic; Continuous performance test; Endophenotype; Monoamine oxidase A; Neuropsychological functioning; Polymorphism; Promoter; QTL; TOVA; Transmission disequilibrium test

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); DNA; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE; METHYLPHENIDATE; NORADRENALIN; SEROTONIN;

ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD; ENZYMOLOGY; FAMILY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HETEROZYGOTE DETECTION; HUMAN; MALE; NUCLEOTIDE REPEAT; PROMOTER REGION; PSYCHOLOGIC TEST; X CHROMOSOME; ADULT; ALLELE; ATTENUATION; CASE CONTROL STUDY; CHILD; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DOPAMINE RELEASE; ENZYME ANALYSIS; FAMILIAL DISEASE; GENETIC ASSOCIATION; HETEROZYGOTE; MAJOR CLINICAL STUDY; MENTAL DISEASE; POPULATION RISK; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUANTITATIVE TRAIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TEST OF VARIABLES OF ATTENTION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHROMOSOMES, HUMAN, X; DNA; FAMILY; FEMALE; GENOTYPE; HETEROZYGOTE DETECTION; HUMANS; MALE; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSYCHOLOGICAL TESTS; REPETITIVE SEQUENCES, NUCLEIC ACID; HUMAN; POLYMORPHISM (GENETICS); SUPPORT, NON-U.S. GOV'T; X CHROMOSOME;

EID: 0036024267     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001037     Document Type: Article

References (65)

1. DSM-IV AD/HD: Confirmatory factor models, prevalence, and gender, age differences based on parent teacher ratings of Australian primary school children
2. DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population
3. Organization of the human monoamine oxidase genes long-range physical mapping around them
4. Monoamine oxidase in neuropsychiatry and behavior
5. Reversible monoamine oxidase-A inhibitors in resistant major depression
6. Current status of antidepressants: Clinical pharmacology and therapy
7. MAOA deficiency and abnormal behaviour: Perspectives on an association
8. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
9. Screening the monoamine oxidase B gene in 100 male patients with schizophrenia: A cluster of polymorphisms in African-Americans but lack of functionally significant sequence changes
10. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population
11. Dinucleotide repeat polymorphism at the MAOA locus
12. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif
13. A functional polymorphism in the monoamine oxidase A gene promoter
14. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder
15. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat
16. Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders
17. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder
18. Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms
19. Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder
20. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: Results of a multicenter study
21. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity
22. Different allele distribution of a regulatory Maoa gene promoter polymorphism in antisocial and anxious-depressive alcoholics
23. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with anti-social alcoholism
24. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder
25. Examining for association between candidate gene polymorphisms in the dopamine pathway and attention-deficit hyperactivity disorder: A family- based study
26. Association between attention deficit hyperactivity disorder and the DXS7 locus
27. The transmission/disequilibrium test: History, subdivision and mixture
28. Transmission test for linkage disequilibrium: The insulin gene region andi insulin-dependent diabetes mellitus (IDDM)
29. Clinical utility of the Test of Variables of Attention (TOVA) in the diagnosis of attention-deficit/hyperactivity disorder
30. Developmental normative data on the test of variables of attention (T.O.V.A.)
31. Closing in on genes for manic-depressive illness and schizophrenia
32. Alternative phenotypes for the complex genetics of schizophrenia
33. Genes for human personality traits: 'Endophenotypes' of psychiatric disorders?
34. Effect of Comt Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
35. Linkage analysis with biological markers
36. Rating scales in attention-deficit/hyperactivity disorder: Use in assessment and treatment monitoring
37. Behavioral problems and competencies reported by parents of normal and disturbed children aged four through sixteen
38. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci
39. Personality and polymorphisms of genes involved in aminergic neurotransmission
40. Genetics of personality dimensions
41. Impulsive choice induced in rats by lesions of the nucleus accumbens core
42. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives
43. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain
44. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers
45. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder
46. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants
47. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
48. Dopamine genes and ADHD
49. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder
50. Cognitive neuro science of attention deficit hyperactivity disorder and hyperkinetic disorder
51. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment
52. Escalating dose-binge treatment with methylphenidate: Role of serotonin in the emergent behavioral profile
53. Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder
54. Functional polymorphism within the promotor of the serotonin transporter gene is associated with severe hyperkinetic disorders
55. Family based association study of the serotonin transporter promoter-region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder (ADHD)
56. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity
57. An animal model of attention deficit hyperactivity disorder
58. Genetics of the risk for alcoholism
59. Sustained attention deficits as markers of genetic susceptibility to schizophrenia
60. QTL association analysis of the DRD4 exon 3 VNTR polymorphism in a population sample of children screened with a parent rating scale for ADHD symptoms
61. Psychiatric genetics: Search for phenotypes
62. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia
63. Quantitative neural indicators of liability to schizophrenia: Implications for molecular genetic studies